Trials / Unknown
UnknownNCT06021418
Efficacy and Safety of DKB-119 in Patients in Crow's Feet
A Single Center, Randomized, Subject and Evaluator Blinded, Split-face, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of DKB-119 in Crow's Feet
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Dongkook Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety DKB-119 and control for patients in crow's feet
Detailed description
A single center, randomized, subject and evaluator blinded, split-face, pivotal clinical trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DKB-119 | Experimental and Acitve Comparator are applied 4 times to each of crow's feet on both sides of the subject. |
Timeline
- Start date
- 2020-11-02
- Primary completion
- 2023-09-08
- Completion
- 2023-10-31
- First posted
- 2023-09-01
- Last updated
- 2023-09-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06021418. Inclusion in this directory is not an endorsement.